Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition
To access this article, please choose from the options below
PII: S0002-9149(02)03420-3
doi:10.1016/S0002-9149(02)03420-3
© 2003 Excerpta Medica Inc. All rights reserved.
